Background illustration for clinical trials search

Paid Clinical Trials Tacoma

Discover 1,461 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Tacoma WA, Renton WA, Seattle WA, Redmond WA, Victoria,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Tacoma WA, Glendale CA, Los Angeles CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06380751

Phase 3, Recruiting

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Tacoma WA, Edmonton, Walnut Creek CA, Las Vegas NV,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06350097

Phase 3, Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Tacoma WA, Wenatchee WA, Vancouver WA, Vancouver,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase 3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Tacoma WA, Seattle WA, Silverdale WA, Spokane WA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Tacoma WA, Sacramento CA, Saskatoon, Regina,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase 3, Recruiting

Prospective Study of Adjunctive Carotenoids Plus Anti-oxidants in Anti-VEGF Treated Diabetic Macular Edema

for
Center-involved Diabetic Macular Edema (CI-DME)
Location: Tacoma WA, Olympia WA
Sponsor: ZeaVision, LLC

Sex: All

Age: 18 - 70+

Code: NCT03866005

Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Tacoma WA, Seattle WA, Portland OR, San Francisco CA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase 3, Recruiting

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis (UC), Severe Ulcerative Colitis,
Location: Tacoma WA, Bellevue WA, San Diego CA, Sun City AZ,
Sponsor: Palisade Bio

Sex: All

Age: 18 - 70+

Code: NCT07845487

Phase 2, Recruiting

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

for
Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC),
Location: Tacoma WA, Bellevue WA, Silverdale WA, Las Vegas NV,
Sponsor: Mirador Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07113522

Phase 2, Recruiting

The Fourth Left Atrial Appendage Occlusion Study

for
Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Location: Tacoma WA, Vancouver, Coeur d'Alene ID, Boise ID,
Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 18+

Code: NCT05963698

Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

for
Carcinoma, Non-Small Cell Lung,
Location: Tacoma WA, Olympia WA, Seattle WA, Edmonds WA,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04389632

Phase 1, Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: Tacoma WA, Seattle WA, Bellevue WA, Vancouver, Calgary,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: Tacoma WA, Seattle WA, Bellevue WA, Vancouver, Calgary,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase 3, Recruiting

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

for
Crohn's Disease
Location: Tacoma WA, Seattle WA, Boise ID, Calgary, Edmonton,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06548542

Phase 2, Recruiting

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

for
Crohn Disease, Colitis, Ulcerative
Location: Tacoma WA, Lubbock TX, Liberty MO, Southlake TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0+

Code: NCT06651281

Phase 3, Recruiting

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

for
Colitis, Ulcerative
Location: Tacoma WA, Los Alamitos CA, Littleton CO, La Jolla CA,
Sponsor: Pfizer

Sex: All

Age: 18 - 64

Code: NCT06398626

Recruiting

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Tacoma WA, Seattle WA, Redwood City CA, Lancaster CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819891

Phase 3, Recruiting

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

for
Crohn's Disease, Ulcerative Colitis
Location: Tacoma WA, Bellevue WA, Vancouver WA, Boise ID,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07697456

Phase 2, Recruiting

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

for
Colitis, Ulcerative
Location: Tacoma WA, Portland OR, Vancouver, Edmonton,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07577856

Phase 3, Recruiting